- Espra 40mg is primarily indicated in conditions like Gastric ulcer, Gastroesophageal reflux disease, NSAID-associated ulceration, Zollinger-ellison syndrome, and can also be given in adjunctive therapy as an alternative drug of choice in Pernicious anaemia and other macrocytic anaemias
- Espra 40mg is contraindicated in conditions like Hypersensitivity to the drug
- The severe or irreversible adverse effects of Espra 40mg, which give rise to further complications include Liver damage. The symptomatic adverse reactions produced by Espra 40mg are more or less tolerable and if they become severe, they can be treated symptomatically, these include Flatulence, Dizziness, Headache. Fatigue, Diarrhea, Myalgia, Constipation, Abdominal pain, Dry mouth, Blurred vision, Rashes, Pruritus, Malaise, Arthralgia, Nausea and vomiting, Musculoskeletal pain, Dry mouth, dizziness, subacute myopathy, athralgia
- Espra 40mg should be given with caution in patients with renal impairment, liver disease, in pregnancy and in breast-feeding. Proton pump inhibitors may mask symptoms of gastric cancer, particular care is required in those whose symptoms change and in those over 45 years of age; the presence of gastric malignancy should be excluded before treatment.